These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23385835)

  • 1. Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice.
    Winnard D; Wright C; Jackson G; Gow P; Kerr A; McLachlan A; Orr-Walker B; Dalbeth N
    N Z Med J; 2012 Jan; 126(1368):53-64. PubMed ID: 23385835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National prevalence of gout derived from administrative health data in Aotearoa New Zealand.
    Winnard D; Wright C; Taylor WJ; Jackson G; Te Karu L; Gow PJ; Arroll B; Thornley S; Gribben B; Dalbeth N
    Rheumatology (Oxford); 2012 May; 51(5):901-9. PubMed ID: 22253023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic differences in cardiovascular disease risk factors and diabetes status for Pacific ethnic groups and Europeans in the Diabetes Heart and Health Survey (DHAH) 2002-2003, Auckland New Zealand.
    Sundborn G; Metcalf PA; Gentles D; Scragg RK; Schaaf D; Dyall L; Black P; Jackson R
    N Z Med J; 2008 Sep; 121(1281):28-39. PubMed ID: 18797481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999-2009.
    Robinson PC; Merriman TR; Herbison P; Highton J
    Rheumatology (Oxford); 2013 Jan; 52(1):118-26. PubMed ID: 22989425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated prevalence of cardiovascular disease and distribution of cardiovascular risk in New Zealanders: data for healthcare planners, funders, and providers.
    Wells S; Broad J; Jackson R
    N Z Med J; 2006 Apr; 119(1232):U1935. PubMed ID: 16633394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use.
    Novak S; Melkonian AK; Patel PA; Kleinman NL; Joseph-Ridge N; Brook RA
    Curr Med Res Opin; 2007 Mar; 23(3):623-30. PubMed ID: 17355743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic and socioeconomic disparities in the prevalence of cardiovascular disease in New Zealand.
    Chan WC; Wright C; Riddell T; Wells S; Kerr AJ; Gala G; Jackson R
    N Z Med J; 2008 Nov; 121(1285):11-20. PubMed ID: 19079433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population.
    Shah M; Butler M; Bramley T; Curtice TG; Fine S
    Curr Med Res Opin; 2007 Feb; 23(2):417-26. PubMed ID: 17288695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for cardiovascular disease in Canada.
    Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
    Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout and its comorbidities in the total population of Stockholm.
    Wändell P; Carlsson AC; Ljunggren G
    Prev Med; 2015 Dec; 81():387-91. PubMed ID: 26500085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with recurrent hospital admissions for gout: a case-control study.
    Hutton I; Gamble G; Gow P; Dalbeth N
    J Clin Rheumatol; 2009 Sep; 15(6):271-4. PubMed ID: 19734730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
    Song SH; Hardisty CA
    QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
    Colvine K; Kerr AJ; McLachlan A; Gow P; Kumar S; Ly J; Wiltshire C; Robinson E; Dalbeth N
    N Z Med J; 2008 Nov; 121(1285):73-81. PubMed ID: 19079439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New urate-lowering therapies in Aotearoa New Zealand: a response to Dr Lance Gravatt's letter on benzbromarone hepatotoxicity.
    Dalbeth N; Gow P; Stamp L; Merriman T; Stuart R; Winnard D; Lindsay K;
    N Z Med J; 2013 Sep; 126(1382):120-3. PubMed ID: 24154780
    [No Abstract]   [Full Text] [Related]  

  • 16. Gender differences in the prevalence, causes and treatment of high cardiovascular risk: findings from the FINRISK Survey.
    Lehto HR; Lehto S; Havulinna AS; Jousilahti P; Salomaa V
    Eur J Prev Cardiol; 2012 Oct; 19(5):1153-60. PubMed ID: 21890534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the Diabetes, Heart and Health Survey.
    Metcalf PA; Scragg RR; Schaaf D; Dyall L; Black PN; Jackson RT
    N Z Med J; 2008 Feb; 121(1269):45-56. PubMed ID: 18278081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of diabetes mellitus and cardiovascular disease among immigrants from Turkey and Morocco and the indigenous Dutch population].
    Dijkshoorn H; Uitenbroek DG; Middelkoop BJ
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1362-6. PubMed ID: 12892013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major cardiovascular disease (CVD) during 1997-1999 and major CVD hospital discharge rates in 1997 among women with diabetes--United States.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Nov; 50(43):948-54. PubMed ID: 11708592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population.
    Hajat C; Shather Z
    Diabetes Res Clin Pract; 2012 Dec; 98(3):481-6. PubMed ID: 23140808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.